Theragene Pharmaceuticals Company
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Biotechnology, Pharmaceutical, Therapeutics
Investors Number:
1
Last Funding Date:
2017
Technology:
Cancer
Founded Date:
2011
Investor Type:
Early Stage Venture
Headquarters:
San Diego, California, United States
Total Funding:
548000
Last Funding Type:
Convertible Note
Employee Number:
1-10